https://www.fortunebusinessinsights.com/ai-in-medical-diagnostics-market-111351
AI in Diagnostics Market Demand Outlook: Rising
Investments in AI-Enabled Diagnostic Platforms
The AI in diagnostics market is expanding rapidly as healthcare providers adopt advanced artificial
intelligence tools to improve accuracy, speed, and efficiency in disease detection. AI systems are being used
extensively in radiology, pathology, cardiology, oncology, and neurology to assist with imaging
interpretation, predictive analytics, and data-driven diagnosis. Driven by a global shortage of specialists,
rising chronic disease cases, and increased funding for AI adoption, this market is projected to grow at
impressive rates worldwide. Major players such as Microsoft, NVIDIA, and Google are leading the effort to
integrate AI capabilities into clinical workflows. As regulatory frameworks evolve and digital healthcare
adoption increases, AI in diagnostics is expected to become a core component of modern medical practice.
According to Fortune Business Insights, the global AI in diagnostics market size was valued at USD 5.15
billion in 2024. The market is projected to grow from USD 7.03 billion in 2025 to USD 96.52 billion by
2032, exhibiting a CAGR of 45.4% during the forecast period. North America dominated the AI in
diagnostics market with a market share of 51.46% in 2024.
Top Companies Leading the Innovation
Amazon.com, Inc. (U.S.)
Microsoft Corporation (U.S.)
NVIDIA Corporation (U.S.)
Google (U.S.)
Siemens Healthcare Private Limited (Germany)
Aidoc (Israel)
PathAI, Inc. (U.S.)
Digital Diagnostics Inc. (U.S.)
Tempus AI (U.S.)
Qure.ai (U.S.)
Key Industry Development: December 2024
Siemens Healthineers AG and DeepHealth, Inc. announced a strategic partnership to integrate AI-powered
informatics into ultrasound workflows—marking a significant step in enabling smarter imaging hardware.
This collaboration exemplifies how legacy medical technology brands are adopting AI to enhance diagnostic
accuracy and streamline clinical operations.
Drivers & Restraints
Main Drivers
Surge in Chronic Diseases: A rising prevalence of conditions like cancer, cardiovascular illness,
and neurological disorders is pushing demand for rapid, precise diagnostic tools. For instance,
breast cancer cases in the U.S. are projected to reach approximately 310,720 women and 2,800
men in 2024 alone.
Healthcare Workforce Shortages: Radiology and pathology are significantly understaffed—UK
radiology staff shortages were estimated at 1,939 consultants in 2021, potentially rising to 3,600 by
2025.
Processing Big Data in Real Time: AI accelerates data interpretation and delivers early insights,
especially in oncology, cardiology, and neurology—critical areas where every minute counts.
Key Restraints
Resistance to Adoption: Some healthcare professionals hesitate to embrace AI partially due to
fears of job displacement and concerns about the reliability of automated tools—posing a challenge
to faster implementation.
Market Segmentation
By Component
Solutions/Software
Commanding the largest market share in 2024, this segment comprises AI algorithms and analytics
platforms. Continuous collaborations between tech giants and med-tech firms are driving rapid innovation in
diagnostic capabilities.
Services
This segment is growing steadily and includes consulting, implementation, and maintenance services. As
more healthcare providers adopt AI, demand for expert service providers continues to rise.
By Specialty
Oncology
Oncology holds the leading market share, propelled by the global cancer burden and a strong demand for
early and accurate diagnostic tools.
Neurology, Pathology, Others
These specialties are witnessing growing AI integration. AI assists in early diagnosis of neurological
disorders and enables automation in pathological image interpretation.
By End-User
Hospitals & Clinics
The primary adopters of AI-driven diagnostics, benefiting from established infrastructure and high patient
inflow.
Diagnostic & Imaging Centers
Increasingly relying on AI to enhance accuracy and efficiency in interpreting CT, MRI, and X-ray results.
Research & Academic Institutions
Critical contributors to AI development, focusing on research, validation, and clinical trial implementation.
Regional Market Insights
North America
Dominating the global landscape, the region reached a valuation of USD 2.65 billion in 2024, thanks to
strong digital infrastructure, advanced AI adoption, and the presence of leading technology providers.
https://www.fortunebusinessinsights.com/ai-in-medical-diagnostics-market-111351
United States
A major innovation hub, with partnerships like GE Healthcare and AWS accelerating the deployment of
generative AI models in diagnostics.
Asia-Pacific
Poised as the fastest-growing market, driven by rising chronic disease rates and a shortage of skilled
radiologists. In March 2025, a Hyderabad-based hospital deployed AI solutions for early detection
of breast, lung, and pancreatic cancers.
Explore the full research report with detailed insights and
TOC: https://www.fortunebusinessinsights.com/ai-in-medical-diagnostics-market-111351
Future Potential and Market Outlook
The AI in diagnostics market is far from maturity, with a projected CAGR of 45.4% through 2032,
indicating substantial untapped opportunities.
Key Growth Areas
Expansion into Under-Served Specialties
AI has yet to be widely implemented in areas such as ophthalmology, autoimmune disorders, and infectious
disease diagnostics.
Precision Diagnostics
Government agencies and venture capitalists are increasing investments to support AI tools tailored for
personalized and accurate diagnoses.
Generative AI Models
Deep partnerships—like Microsoft and NVIDIA—are paving the way for advanced imaging solutions
powered by generative AI, enhancing clinical decision-making.
Broader Clinical Integration
AI is increasingly being embedded into PACS, EHRs, and radiology systems. The Siemens and
DeepHealth collaboration showcases how integration is optimizing diagnostic workflows
Conclusion
The AI in Diagnostics market is set to redefine global healthcare delivery. From cost reduction to early
disease detection and remote diagnostics, the shift is monumental. Reaching USD 96.5 billion by 2032—with
an impressive CAGR of 45%—this is not just technology evolution—it’s a paradigm shift. Bolstered by
innovation, investment, and integration, AI-enabled diagnostics will soon become standard practice—
ushering in a future of smarter, faster, and more accessible healthcare for all.
About Us:
Fortune Business Insights provides expert corporate analysis and accurate data, enabling businesses of all
sizes to make timely decisions. We offer customized solutions tailored to each client’s needs, helping them
address unique challenges. Our goal is to empower clients with holistic market intelligence and offer
granular insights into the market they operate in.
At Fortune Business Insights, we aim to highlight growth opportunities for our clients, offering insights and
recommendations that help them navigate technological and market changes. Our consulting services are
designed to help companies uncover hidden opportunities and address competitive challenges.
Contact us:
Fortune Business Insights™ Pvt.
Phone: USA: +1 833 909 2966 (Toll-Free),
United Kingdom: +44 808 502 0280 (Toll-Free),
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com